Goettingen | Washington DC, January 22, 2013 – Alan Burns, Vice President of Quality Management at pharma and biotech supplier Sartorius Stedium Biotech, has been elected to the Board of Directors of Rx-360. This is an international pharmaceutical supply chain consortium. Burns has been appointed for a three-year term, together with six other individuals from the pharmaceutical and biotech industry, who include both manufacturers and suppliers. Rx-360 is a not for profit association. Its purpose is to enhance the security of the pharmaceutical supply chain and to assure the quality and authenticity of the products moving through this supply chain.
Rx-360 has also elected new officers. Brian Johnson, Senior Director Supply Chain Security at Pfizer will serve as the Rx-360 Chair and Guy Villax, Chief Executive at Hovione, as Vice Chair.